Literature DB >> 35841522

Surface molecularly imprinted solid-phase extraction for the determination of vancomycin in plasma samples using HPLC-MS/MS.

Hao Zhou1,2, Qianqian Chen1, Xuqin Song3, Limin He1, Rong Liu4.   

Abstract

Vancomycin is a glycopeptide antibiotic used to treat infections caused by Gram-positive bacteria. Due to the narrow therapeutic index of vancomycin, it is necessary to develop a sensitive and reliable analytical method to monitor the drug concentration in plasma. A novel method based on surface molecularly imprinted solid-phase extraction combined with liquid chromatography-tandem mass spectrometry for the determination of vancomycin in plasma sample was developed. The plasma sample was cleaned up through the solid-phase extraction process before the analysis. The calibration standard of vancomycin in plasma ranged between 1 and 100 ng/mL, and the correlation coefficient (r) was 0.9993. The average recoveries were from 94.3 to 104.0%, and the precision was less than 10.5%. The limit of detection and limit of quantification were 0.5 ng/mL and 1 ng/mL, respectively. The method validated was successfully used for the detection of vancomycin in mice after oral administration.
© 2022. The Author(s), under exclusive licence to The Japan Society for Analytical Chemistry.

Entities:  

Keywords:  LC–MS/MS; Plasma; Solid-phase extraction; Surface molecularly imprinted polymers; Vancomycin

Mesh:

Substances:

Year:  2022        PMID: 35841522     DOI: 10.1007/s44211-022-00143-1

Source DB:  PubMed          Journal:  Anal Sci        ISSN: 0910-6340            Impact factor:   1.967


  8 in total

1.  A sensitive HPLC-UV method for quantifying vancomycin in biological matrices: Application to pharmacokinetic and biodistribution studies in rat plasma, skin and lymph nodes.

Authors:  Delly Ramadon; Aaron J Courtenay; Andi Dian Permana; Ismaiel A Tekko; Emma McAlister; Maelíosa T C McCrudden; Helen O McCarthy; Ryan F Donnelly
Journal:  J Pharm Biomed Anal       Date:  2020-06-17       Impact factor: 3.935

2.  A rapid and simple UPLC method for serum vancomycin determination in pediatric patients undergoing continuous infusion or intermittent infusion of vancomycin.

Authors:  Min Zhang; XiaoLan Huang; Wu Yahui; Chong Shi; Pei Pei; Jian Yang; Qu Dong; Xiaodai Cui
Journal:  J Pharm Biomed Anal       Date:  2019-05-29       Impact factor: 3.935

3.  Development of a deep eutectic solvent-based ultrasound-assisted homogenous liquid-liquid microextraction method for simultaneous extraction of daclatasvir and sofosbuvir from urine samples.

Authors:  Abolghasem Jouyban; Mir Ali Farajzadeh; Fariba Khodadadeian; Maryam Khoubnasabjafari; Mohammad Reza Afshar Mogaddam
Journal:  J Pharm Biomed Anal       Date:  2021-07-08       Impact factor: 3.935

4.  Ultra-high performance liquid chromatography tandem mass spectrometry for the determination of five glycopeptide antibiotics in food and biological samples using solid-phase extraction.

Authors:  Fenfang Deng; Hong Yu; Xinhong Pan; Guoyuan Hu; Qiqin Wang; Rongfei Peng; Lei Tan; Zhicong Yang
Journal:  J Chromatogr A       Date:  2018-02-23       Impact factor: 4.759

5.  Monitoring of vancomycin in human plasma via portable microchip electrophoresis with contactless conductivity detector and multi-stacking strategy.

Authors:  Kah Chun Chong; Lee Yien Thang; Joselito P Quirino; Hong Heng See
Journal:  J Chromatogr A       Date:  2017-01-05       Impact factor: 4.759

6.  Multi-residue determination of 115 veterinary drugs and pharmaceutical residues in milk powder, butter, fish tissue and eggs using liquid chromatography-tandem mass spectrometry.

Authors:  Marilena E Dasenaki; Nikolaos S Thomaidis
Journal:  Anal Chim Acta       Date:  2015-04-09       Impact factor: 6.558

7.  Simultaneous quantification of antimicrobial agents for multidrug-resistant bacterial infections in human plasma by ultra-high-pressure liquid chromatography-tandem mass spectrometry.

Authors:  I-Lin Tsai; Hsin-Yun Sun; Guan-Yuan Chen; Shu-Wen Lin; Ching-Hua Kuo
Journal:  Talanta       Date:  2013-07-26       Impact factor: 6.057

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.